FDA Warns Individuals And Firms To Stop Selling Fake Cancer 'Cures' (Medical News Today)
Warning Letters have been sent to 23 U.S. companies and two foreign individuals marketing a wide range of products fraudulently claiming to prevent and cure cancer, according to the U.S. Food and Drug Administration.

Glenmark Generics launches trandolapril tabs in US (PharmaBiz)
Glenmark Generics Ltd (GGL), a subsidiary of Glenmark Pharmaceuticals Ltd. has received ANDA approval from the US FDA for trandolapril tablets USP 1 mg, 2 mg and 4 mg and will immediately commence marketing and distribution of these products in the US market.

Synapse Biomedical Receives FDA Approval Of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing ... (Medical News Today)
Synapse Biomedical Inc. (http://www.synapsebiomedical.com) announced it has received approval from the U.S. Food and Drug Administration (FDA) for its NeuRx DPS(TM) for ventilator-dependent Spinal Cord Injury (SCI) patients who lack voluntary control of their diaphragms. With the FDA's approval, SCI patients and their caregivers throughout the U.S.